Viewing Study NCT00304460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-05-06 @ 9:46 AM
Study NCT ID: NCT00304460
Status: COMPLETED
Last Update Posted: 2019-12-12
First Post: 2006-03-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
None Renal Cell Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Serum Protein Levels View
None Lymphocyte Phenotypes View
None Predictive Analysis View
None Serum Cytokines View
None Kidney Cancer View
None Renal Cell Cancer View
None Melanoma View
None Metastatic Melanoma View